Advertisement

Topics

Coming of age, Israel biotech sector gets ready for market

08:06 EDT 17 Aug 2017 | Topix

The sale of Israeli drugmaker NeuroDerm to Japanese pharma giant Mitsubishi Tanabe for $1.1 billion last month in the largest ever purchase of an Israeli healthcare company, has put the spotlight on Israel's biotech sector, where a number of other firms are gearing up for commercialization of their product. "This is a big deal," said Anya Eldan, vice president of the Israel Innovation Authority's Startup Division, about the NeuroDerm deal.

Original Article: Coming of age, Israel biotech sector gets ready for market

NEXT ARTICLE

More From BioPortfolio on "Coming of age, Israel biotech sector gets ready for market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...